Correlation Between Molecular Templates and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Terns Pharmaceuticals, you can compare the effects of market volatilities on Molecular Templates and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Terns Pharmaceuticals.
Diversification Opportunities for Molecular Templates and Terns Pharmaceuticals
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Molecular and Terns is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Molecular Templates i.e., Molecular Templates and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Molecular Templates and Terns Pharmaceuticals
Given the investment horizon of 90 days Molecular Templates is expected to under-perform the Terns Pharmaceuticals. In addition to that, Molecular Templates is 2.31 times more volatile than Terns Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 1,315 in Terns Pharmaceuticals on August 30, 2024 and sell it today you would lose (681.00) from holding Terns Pharmaceuticals or give up 51.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Molecular Templates |
| Terns Pharmaceuticals |
Molecular Templates and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Terns Pharmaceuticals
The main advantage of trading using opposite Molecular Templates and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Molecular Templates vs. Bright Minds Biosciences | Molecular Templates vs. HP Inc | Molecular Templates vs. Intel | Molecular Templates vs. Chevron Corp |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |